Preclinical study
Online First™Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
Tobias J. Grob, Uwe Heilenkötter, Stefan Geist, Peter Paluchowski and Christian Wilke, et al.
Online First™, 19 May 2012
Clinical Trial
Online First™Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
Ivana Sestak, Michelle Harvie, Anthony Howell, John F. Forbes and Mitch Dowsett, et al.
Online First™, 16 May 2012
Clinical Trial
Online First™Early breast cancer with positive margins: excellent local control with an upfront brachytherapy boost
Thomas M. Schroeder, Ben Liem, Sagus Sampath, William R. Thompson and Janet Longhurst, et al.
Online First™, 16 May 2012
Preclinical Study
Online First™Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
Jun Tang, Rong Deng, Rong-Zhen Luo, Guo-Ping Shen and Mu-Yan Cai, et al.
Online First™, 15 May 2012
Preclinical Study
Online First™Analysis of KLLN as a high-penetrance breast cancer predisposition gene
Ella R. Thompson, Kylie L. Gorringe, David Y. H. Choong, Diana M. Eccles and kConFab, et al.
Online First™, 13 May 2012
Preclinical Study
Online First™SGK3 is associated with estrogen receptor expression in breast cancer
Jun Xu, Ma Wan, Quanyuan He, Roland L. Bassett Jr and Xiaoyong Fu, et al.
Online First™, 11 May 2012
Letter to the Editor
Online First™Comment on the review by Joshi and Buehring
James F. Holland and Beatriz G.-T. Pogo
Online First™, 6 May 2012
Preclinical Study
Online First™Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer
Alaa T. Alshareeda, Emad A. Rakha, Christopher C. Nolan, Ian O. Ellis and Andrew R. Green
Online First™, 6 May 2012
Clinical Trial
Online First™Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
William Jacot, Stéphane Pouderoux, Simon Thezenas, Angélique Chapelle and Jean-Pierre Bleuse, et al.
Online First™, 6 May 2012
Preclinical Study
Online First™Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho and Amarnath Natarajan
Online First™, 6 May 2012